Literature DB >> 12181384

Effects of obesity phenotype on coronary heart disease risk factors in response to weight loss.

Tomohiro Okura1, Kiyoji Tanaka, Tomoko Nakanishi, Dong Jun Lee, Yoshio Nakata, Seung Wan Wee, Hiroshi Shimokata.   

Abstract

OBJECTIVE: To determine whether there is a difference in risk-factor improvement for coronary heart disease (CHD) between the intra-abdominal fat (IF) and subcutaneous fat (SF) obesity phenotypes after weight loss. RESEARCH METHODS AND PROCEDURES: Subjects included 55 mildly obese women (body mass index, 25 to 36 kg/m(2); age range, 34 to 63 years) who had at least two of three CHD risk factors [systolic blood pressure (SBP), >140 mm Hg; total cholesterol (TC), >220 mg/dL; fasting plasma glucose, >110 mg/dL). Using computed tomography, IF obesity was classified as > or =110 cm(2) of the IF area measured; subjects with <110 cm(2) were classified as having SF obesity. The IF and SF obesity groups were divided into diet-only and diet-plus-exercise groups. Assays and measurements were performed before and after a 14-week (98-day) intervention.
RESULTS: Weight was reduced by 7 to 10 kg in each group. The IF and SF areas, SBP, diastolic blood pressure, TC, and low-density lipoprotein-cholesterol were significantly reduced in all groups (p < 0.01). Reduction in IF area was greater in IF obesity than in SF obesity, whereas no differences were observed in the improvement of CHD risk factors. Sample sizes needed for observing a significant difference for SBP, TC, triglycerides, and fasting plasma glucose were greater than the number of subjects in this study. DISCUSSION: Our results suggest that the influence of the obesity phenotype on improving CHD risk factors is not apparent. A larger study is needed to prove the validity of this finding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181384     DOI: 10.1038/oby.2002.103

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  6 in total

Review 1.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

2.  The fallacy of ratio correction to address confounding factors.

Authors:  Natasha A Karp; Anne Segonds-Pichon; Anna-Karin B Gerdin; Ramiro Ramírez-Solis; Jacqueline K White
Journal:  Lab Anim       Date:  2012-07       Impact factor: 2.471

3.  Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial.

Authors:  Xiaomin Zhang; Qibin Qi; Jun Liang; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Hypertension       Date:  2012-09-10       Impact factor: 10.190

4.  Allometric relationship between changes of visceral fat and total fat mass.

Authors:  C E Hallgreen; K D Hall
Journal:  Int J Obes (Lond)       Date:  2007-12-18       Impact factor: 5.095

5.  Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes.

Authors:  Tae Sasakabe; Hajime Haimoto; Hiroyuki Umegaki; Kenji Wakai
Journal:  Diabetes Metab Syndr Obes       Date:  2011-04-29       Impact factor: 3.168

Review 6.  Comparisons of calorie restriction and structured exercise on reductions in visceral and abdominal subcutaneous adipose tissue: a systematic review.

Authors:  Takashi Abe; Jun Seob Song; Zachary W Bell; Vickie Wong; Robert W Spitz; Yujiro Yamada; Jeremy P Loenneke
Journal:  Eur J Clin Nutr       Date:  2021-05-26       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.